Ledidi is rapidly emerging as a transformative force in health research. Through its flagship software platform Ledidi Core, the Norwegian health tech innovator is redefining how the global health and life science community collaborates, analyzes, and secures sensitive clinical data. 

In Norway, Ledidi supplies several health trusts that cover research and quality registries, but their solutions know no borders and are in use in 25 countries.  

−  Research is tomorrow’s medicine. Quality registries are about ensuring that today’s treatment meets desired goals and standards. These registries identify procedures that are going well, and things that are not going well. The old-fashioned way of doing this is to register everything that can go wrong. What you lose then are all the factors that identify why things are going well. Registering quality is about logging the entire patient journey – efficiency improvements, identifying whether procedures provide marginal or large gains and so forth. It also involves benchmarking against other hospitals and clinics that are comparable. We provide a secure and user-friendly platform that can be used for this mapping, says Ledidi CEO and co-founder Einar Martin Aandahl. 

A lot of the value in the platform is the end-user perspective. Ledidi provides a flexible “do it yourself” solution for different needs.

−  Our software helps clinicians and researchers collaborate with health data within the boundaries of privacy and data security.  We deliver a system that allows you to aggregate more health data across the medical record systems. We deliver structured health data, which allows you to gain more insight. It’s a very flexible platform for collecting, structuring and analyzing data, says Aandahl. 

While Ledidi Core prominently addresses the needs of researchers and clinicians, administrative personnel in healthcare organizations equally benefit from its streamlined, secure, and efficient processes.

From an administrative standpoint, Ledidi Core reduces complexity by integrating multiple health record systems into a single, cohesive platform. This integration simplifies administrative tasks such as regulatory compliance reporting, oversight of data management, and monitoring of quality standards. The software automates and simplifies data aggregation, drastically cutting down the administrative burden traditionally associated with managing disparate data sets.

Administrators benefit from real-time access to structured data, allowing for improved resource allocation and decision-making. Ledidi’s robust security protocols ensure compliance with stringent regulatory standards such as GDPR, significantly reducing administrative risks related to data breaches or non-compliance.

Furthermore, the platform’s intuitive, user-friendly design minimizes training requirements for administrative staff, leading to rapid adoption and increased operational efficiency.

– By enhancing collaboration between researchers, clinicians, and administrative staff, Ledidi ensures smoother workflows and better-coordinated healthcare delivery across institutions and international borders, says Ledidi CRO, Kent Jordet.

A keyword for the Norwegian scaleup these days is adoption, and particularly one market has drawn the company’s attention.

−  The UK is a big market, but not very different from Norway, and we see a significant traction in this market now, says Aandahl, who is adapting to a trend that makes their software especially important: precision medicine.

−  It’s becoming increasingly expensive to run clinical trials with fewer patients. More and more selective patient groups require that pharma and biotechs can collaborate more closely with hospitals and research institutions. Our software makes this cross-institutional collaboration much easier and frictionless, says Aandahl.

Ledidi has gone into a collaboration with CMR Surgical – which is one of the largest manufacturers of robotic surgery equipment. Ledidi have also signed agreements with customers like Pfizer, Photocure, Sensocure, Weill Cornell Medicine and multiple NHS Trusts.